|
|
|
|
LEADER |
01877 am a22001933u 4500 |
001 |
117054 |
042 |
|
|
|a dc
|
100 |
1 |
0 |
|a Beyaz, Semir
|e author
|
100 |
1 |
0 |
|a Koch Institute for Integrative Cancer Research at MIT
|e contributor
|
100 |
1 |
0 |
|a Beyaz, Semir
|e contributor
|
100 |
1 |
0 |
|a Yilmaz, Omer
|e contributor
|
700 |
1 |
0 |
|a Yilmaz, Omer
|e author
|
245 |
0 |
0 |
|a Molecular Pathways: Dietary Regulation of Stemness and Tumor Initiation by the PPAR- Pathway
|
260 |
|
|
|b American Association for Cancer Research (AACR),
|c 2018-07-23T19:07:24Z.
|
856 |
|
|
|z Get fulltext
|u http://hdl.handle.net/1721.1/117054
|
520 |
|
|
|a Peroxisome proliferator-activated receptor delta (PPAR-8) is a nuclear receptor transcription factor that regulates gene expression during development and disease states, such as cancer. However, the precise role of PPAR-8 during tumorigenesis is not well understood. Recent data suggest that PPAR-8 may have context-specific oncogenic and tumor-suppressive roles depending on the tissue, cell-type, or diet-induced physiology in question. For example, in the intestine, pro-obesity diets, such as a high-fat diet (HFD), are associated with increased colorectal cancer incidence. Interestingly, many of the effects of an HFD in the stem and progenitor cell compartment are driven by a robust PPAR-8 program and contribute to the early steps of intestinal tumorigenesis. Importantly, the PPAR-8 pathway or its downstream mediators may serve as therapeutic intervention points or biomarkers in colon cancer that arise in patients who are obese. Although potent PPAR-8 agonists and antagonists exist, their clinical utility may be enhanced by uncovering how PPAR-8 mediates tumorigenesis in diverse tissues and cell types as well as in response to diet.
|
520 |
|
|
|a National Institutes of Health (U.S.) (Grant R00-AG045144)
|
655 |
7 |
|
|a Article
|
773 |
|
|
|t Clinical Cancer Research
|